Preeclampsia is one of the most dangerous complications of pregnancy, contributing to an estimated 10 to 15 percent of maternal deaths worldwide and posing serious risks to the baby as well. But its dangers do not end at delivery. Women who survive preeclampsia face sharply elevated odds of heart disease, stroke, and kidney failure in the years and decades that follow, and even the children born from preeclamptic pregnancies carry measurable health consequences into adulthood. The condition sits at an uncomfortable intersection of urgency and uncertainty: delivery remains the only definitive treatment, and the science of prevention is still catching up.
What Preeclampsia Does During Pregnancy
At its core, preeclampsia is a disorder of the placenta. When the placenta implants, it normally remodels the mother’s spiral arteries to create wide, low-resistance blood vessels that supply the fetus with oxygen and nutrients. In preeclampsia, that remodeling fails. The arteries remain narrow, blood flow is restricted, and the oxygen-starved placenta releases distress signals into the mother’s bloodstream, triggering widespread inflammation and damage to the lining of blood vessels throughout her body.1PubMed. Placental Dysfunction as a Common Pathway Linking Preeclampsia, Fetal Growth Restriction, and Preterm Birth: Current Evidence and Future Directions That vascular damage is what makes the condition so dangerous: it does not stay in one place.
The hallmark sign is high blood pressure, usually appearing after 20 weeks of pregnancy, accompanied by protein in the urine or signs of organ stress. When the disease progresses, it can attack almost any organ system. The liver can swell and develop areas of dead tissue. The kidneys can begin to fail. The blood’s clotting system can malfunction. In severe cases, a constellation called HELLP syndrome develops, involving the breakdown of red blood cells, elevated liver enzymes, and dangerously low platelet counts.2International Journal of Gynecology & Obstetrics. Milestones in the quest for best management of patients with HELLP syndrome And if blood pressure spirals out of control, preeclampsia can cross into eclampsia, producing seizures that threaten both the mother’s brain and her life. Magnesium sulfate, the main drug used to prevent and treat eclamptic seizures, works in part by reducing brain swelling and inflammation.3PubMed Central. Magnesium Sulfate Provides Neuroprotection in Eclampsia-Like Seizure Model by Ameliorating Neuroinflammation and Brain Edema
This progression can unfold over weeks or within hours. Some women go from feeling fine to needing an emergency cesarean section in a single day. The unpredictability is part of what makes preeclampsia so frightening for patients and clinicians alike.
How the Baby Is Affected
The same placental failure that harms the mother also starves the fetus. Restricted blood flow through the placenta means less oxygen and fewer nutrients reaching the developing baby, which can cause fetal growth restriction or force an early delivery. Preeclampsia is one of the leading causes of medically indicated preterm birth, and the earlier the delivery, the higher the risk of complications for the newborn, from breathing problems to long-term neurological challenges.1PubMed. Placental Dysfunction as a Common Pathway Linking Preeclampsia, Fetal Growth Restriction, and Preterm Birth: Current Evidence and Future Directions
The consequences do not disappear once the child leaves the hospital. A large population-based study found that children born at term to mothers with preeclampsia had a roughly 60 percent higher rate of hospitalization for endocrine, nutritional, and metabolic diseases, and about a 50 percent higher rate for diseases of the blood and blood-forming organs, compared with unexposed children.4American Journal of Obstetrics and Gynecology. Health of children born to mothers who had preeclampsia: a population-based cohort study Even among babies who were not born small for their gestational age, increased rates of infection, respiratory disease, and congenital malformations were observed. Research also suggests that offspring of preeclamptic pregnancies tend to have higher blood pressure starting in childhood, and face an elevated risk of stroke later in life, with the risk greatest when preeclampsia occurred early in the pregnancy.5Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health. Long term cardiovascular outcomes for mother and child
The Postpartum Period Is Not the Finish Line
Many people assume that once the placenta is delivered, preeclampsia is over. That assumption is wrong, and it can be deadly. Blood pressure often worsens in the first few days after delivery before it improves, and some women develop preeclampsia for the first time in the postpartum period, having had a completely normal pregnancy. One study of more than 23,000 deliveries found that about 1.1 percent of women were readmitted for worsening of a known hypertensive diagnosis and another 0.5 percent were readmitted for new-onset postpartum preeclampsia.6AJOG Global Reports. Factors associated with early readmission for postpartum hypertension
Among women discharged after a preeclamptic pregnancy, about 1.6 percent were readmitted within 60 days for a hypertension-related problem, with the vast majority of those readmissions occurring within the first ten days.7PubMed Central. Postpartum Length of Stay and Risk for Readmission among Women with Preeclampsia The readmission rate was highest among women with superimposed preeclampsia, at about 2 percent. Several factors seem to reduce the chance of readmission: having proteinuria detected during the initial stay, being prescribed blood pressure medications at discharge, and staying in the hospital longer before going home. Older maternal age consistently raised the risk of readmission.8Obstetrics & Gynecology. Factors Associated With Readmission for Postpartum Preeclampsia The practical takeaway is that the first two weeks after discharge deserve close monitoring, particularly for women over 35 or those sent home without blood pressure medication.
Long-Term Heart and Kidney Risks
This is where the danger of preeclampsia becomes most underappreciated. The vascular damage done during a preeclamptic pregnancy does not simply heal. A major meta-analysis, pooling data from studies that controlled for other risk factors, found that women with a history of preeclampsia had roughly four times the risk of developing heart failure, about two and a half times the risk of coronary heart disease, roughly double the risk of stroke, and more than double the risk of dying from cardiovascular disease compared with women who had uncomplicated pregnancies.9PubMed. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis Those numbers are sobering, and they persist even after accounting for factors like obesity and pre-existing high blood pressure.
A large Korean population study and an accompanying meta-analysis confirmed these patterns, finding pooled hazard ratios of about 1.65 for ischemic heart disease and 1.78 for stroke.10PubMed Central. Long-term cardiovascular outcome in women with preeclampsia in Korea: a large population-based cohort study and meta-analysis The underlying mechanisms include lasting changes to the heart’s structure and function, including thickening of the heart’s left wall and impaired filling, which raise the risk of heart failure even decades later.11PubMed Central. Long-Term Cardiovascular Risk and Maternal History of Pre-Eclampsia
The kidneys are equally vulnerable. Women with a history of preeclampsia face an estimated 5- to 12-fold increased risk of end-stage kidney disease.12PubMed Central. Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy A systematic review put the meta-analytic risk ratio for end-stage renal disease at about 6.35 compared with women who had normotensive pregnancies.13PubMed. A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia The risk appears highest in the first five years after the affected pregnancy, but it does not disappear after that. Women with superimposed preeclampsia, meaning they had chronic high blood pressure before developing preeclampsia, may face even steeper risks.14Macedonian Medical Review. Chronic Kidney Disease as a Long-term Consequence of Preeclampsia and Hypertensive Disorders in Pregnancy
Despite these well-documented risks, follow-up screening after a preeclamptic pregnancy is alarmingly poor. An analysis of postpartum care found that only about 14 percent of women had even some of the recommended lab work done within a year of delivery, and just 6 percent were screened with the full recommended panel of tests.15Circulation. Abstract P1169: Postpartum Care in Hypertensive Disorders of Pregnancy: Exploring Factors Affecting Follow-Up The American Heart Association has acknowledged this gap, noting that evidence-based strategies for managing cardiovascular risk in these patients after pregnancy are still lacking.16PubMed Central. Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association
Screening, Prevention, and Current Treatment
There is no single blood test that diagnoses preeclampsia, but a biomarker ratio has emerged as a powerful tool for ruling it out. The ratio of sFlt-1 to PlGF, two proteins involved in blood vessel formation, can help clinicians assess whether a woman with suspicious symptoms is likely to develop preeclampsia in the near term. A large validation study found that when this ratio was 38 or lower, the chance that the woman would not develop preeclampsia within the next week was about 99 percent.17PubMed. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia It is more useful for ruling out the condition than for confirming it: when the ratio was above 38, only about a third of women went on to develop preeclampsia within four weeks. Independent validation showed similarly high diagnostic accuracy.18PubMed Central. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
For prevention, low-dose aspirin is the most studied intervention. Women at high risk are commonly advised to start aspirin early in pregnancy. Whether the dose matters is an area of active debate. One meta-analysis found that a higher dose range of 150 to 162 milligrams reduced preterm preeclampsia by about two-thirds compared with a lower range of 75 to 81 milligrams.19PubMed. Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis However, a larger observational study found no significant difference in preeclampsia rates between the two dose ranges, including no difference in the rate of preeclampsia with preterm birth.20JAMA Network Open. Prophylactic Aspirin Dose and Preeclampsia The evidence, in other words, is not settled, and your clinician’s recommendation may depend on your specific risk profile.
Once preeclampsia develops, the only definitive treatment is delivery. Everything else is about managing the clock: controlling blood pressure, preventing seizures with magnesium sulfate, and monitoring organ function to keep the mother stable long enough for the baby to mature, if gestation allows it.21PubMed Central. The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions Recent work suggests that tailoring blood pressure medication to each woman’s specific circulatory pattern, rather than using a one-size-fits-all drug, can cut the rate of severe hypertension before delivery from about 19 percent to 6 percent.22American Journal of Obstetrics & Gynecology MFM. Tailored treatment of hypertension in pregnancy based on maternal hemodynamic findings New drugs are being investigated as well, including repurposed medications like metformin, proton pump inhibitors, and statins, all of which have shown promise in lab studies targeting placental and vascular dysfunction, but none have yet been proven effective enough to change clinical practice.23PubMed. Novel approaches to combat preeclampsia: from new drugs to innovative delivery
The Psychological Toll
The physical dangers of preeclampsia get most of the attention, but the emotional aftermath deserves more than a footnote. A study following women after preeclamptic pregnancies found that about 9 percent met criteria for post-traumatic stress disorder at six weeks postpartum, and about 5 percent still met criteria at twelve weeks. Nearly 30 percent reported symptoms of hyperarousal, such as being easily startled or unable to sleep, in the early weeks after delivery. Younger women and those who experienced the most severe complications, including neonatal ICU admissions or perinatal death, were hardest hit.24PubMed. Symptoms of post-traumatic stress after preeclampsia
Qualitative research paints an even more troubling picture. Women interviewed years after their preeclamptic pregnancies described feelings of hopelessness, guilt, loneliness, and distress that persisted long after the physical danger had passed. Simply recalling the experience was enough to trigger fear and distress. Many of these women felt that their mental health was neglected by both family members and healthcare professionals, and they expressed a need for long-term psychological follow-up that simply was not available to them.25PubMed Central. Exploring the Long‐Term Emotional Trauma Experiences of Mothers With a History of Preeclampsia: A Qualitative Study If you or someone you know went through a preeclamptic pregnancy and is struggling emotionally, that response is common and warrants professional support.
Recurrence in Future Pregnancies
One of the first questions women ask after a preeclamptic pregnancy is whether it will happen again. The answer is that it might, and the odds are not trivial. One study tracking women through their subsequent pregnancies found a recurrence rate of about 27 percent, with significantly higher recurrence among women whose first preeclamptic pregnancy was also their first pregnancy overall.26PubMed Central. Risk for Recurrence of Pre-eclampsia in the Subsequent Pregnancy
The time between pregnancies matters in an unexpected way. A large study found that the risk of preeclampsia in a second or third pregnancy rose steadily with each additional year of gap between pregnancies, and when the interval reached ten years or more, the risk was essentially the same as being pregnant for the first time. For every extra year between deliveries, the odds of preeclampsia increased by about 12 percent. The study also investigated whether changing partners raised the risk. In raw numbers it appeared to, but once the longer gap between pregnancies was accounted for, a new partner actually showed a slightly reduced risk.27PubMed. The interval between pregnancies and the risk of preeclampsia This finding fits with a broader immunological theory: the mother’s immune system may build tolerance to the father’s antigens over time and with exposure, and a long gap erodes that tolerance.
Racial Disparities and Gaps in Care
Preeclampsia does not affect all groups equally. Black women face particularly high rates of the condition, likely driven by a combination of higher baseline rates of hypertension, possible genetic susceptibility factors including variants in the APOL1 gene, and systemic healthcare disparities that delay diagnosis and reduce access to care.28PubMed Central. Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities The interplay of biology and social determinants means that any conversation about the dangers of preeclampsia must acknowledge that those dangers are unevenly distributed. Addressing this gap is not just a matter of equity but of reducing maternal mortality overall, since communities with the highest preeclampsia burden also tend to have the least access to the specialized postpartum monitoring that could prevent readmissions and catch early signs of long-term damage.
Why Preeclampsia Exists at All
It may seem strange that such a dangerous condition would persist in the human species. One explanation comes from evolutionary biology. Humans have an unusually invasive placenta compared with most other mammals. During implantation, specialized cells from the embryo burrow deep into the uterine wall and extensively reshape the mother’s blood supply. This aggressive strategy is thought to be part of what allowed human fetuses to develop their disproportionately large, energy-hungry brains. But the same invasive mechanism that made human brains possible also created a vulnerability: when the invasion fails or falls short, the consequences are severe.29Applied & Translational Genomics. Evolutionary perspectives into placental biology and disease Preeclampsia, in this view, is a side effect of a reproductive strategy that has been enormously successful for the species but occasionally catastrophic for individuals.
Adding a further layer of complexity, preeclampsia appears to have an immunological dimension linked to the father. The mother’s immune system must learn to tolerate the foreign antigens contributed by the father’s genes to the placenta. Research has found that greater prior exposure to a partner’s seminal fluid through vaginal contact is associated with a significantly lower risk of preeclampsia, with women in the highest exposure category showing about 70 percent reduced odds compared with those in the lowest category.30PubMed. Cumulative exposure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia This aligns with the observation that short relationships before conception, long gaps between pregnancies, and conception through certain assisted reproductive techniques that bypass vaginal exposure all raise the risk.31PubMed Central. Paternal Determinants in Preeclampsia Preeclampsia, in other words, is not purely a maternal condition. It reflects a complex negotiation between the mother’s body, the father’s genetic contribution, and the placenta that bridges them.